Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
J Leukoc Biol ; 88(2): 303-11, 2010 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-20356901

RESUMEN

IL-10, a potent anti-inflammatory cytokine, activates its primary mediator STAT3 to exert inhibitory effects on activated immune response. It has been reported that IFN-gamma signaling can be suppressed by IL-10, which deactivates macrophages and suppresses cell-mediated antigen presentation. Cathepsin S, a cysteine protease, plays a significant role in the antigen processing. We hypothesize that the IL-10-induced and STAT3-mediated signaling pathway interferes with IFN-gamma-induced immune responses in primary human blood macrophages. Here, we investigated whether IL-10 perturbs MHC-II levels via its effect on cathepsin S expression in antigen processing. We showed that the expression of cathepsin S and MHC-II, inducible by IFN-gamma, was down-regulated in the presence of IL-10. Additionally, we revealed that the inhibitory effect of IL-10 was demonstrated to be independent of the classical IFN-gamma-induced JAK2/STAT1 signaling cascade or the NF-kappaB pathway. Following STAT3 suppression with specific siRNA, the expression of IFN-gamma-induced surface MHC-II antigens and cathepsin S levels was restored, even in the presence of IL-10. Taken together, our results demonstrated that the immunosuppressive effects of IL-10-STAT3 on MHC-II antigen presentation may occur via the inhibition of cathepsin S expression.


Asunto(s)
Catepsinas/genética , Antígenos de Histocompatibilidad Clase II/genética , Interleucina-10/farmacología , Macrófagos/inmunología , Factor de Transcripción STAT3/fisiología , Células Sanguíneas , Catepsinas/fisiología , Regulación hacia Abajo/genética , Humanos , Inmunidad , Interferón gamma
2.
BMC Immunol ; 10: 64, 2009 Dec 17.
Artículo en Inglés | MEDLINE | ID: mdl-20017901

RESUMEN

BACKGROUND: Mycobacterium tuberculosis (MTB) is a major cause of morbidity and mortality in the world. To combat against this pathogen, immune cells release cytokines including tumor necrosis factor-alpha (TNF-alpha), which is pivotal in the development of protective granulomas. Our previous results showed that Bacillus Calmette Guerin (BCG), a mycobacterium used as a model to investigate the immune response against MTB, stimulates the induction of TNF-alpha via mitogen-activated protein kinase (MAPK) in human blood monocytes. Since MAPK phosphatase-1 (MKP-1) is known to regulate MAPK activities, we examined whether MKP-1 plays a role in BCG-induced MAPK activation and cytokine expression. RESULTS: Primary human blood monocytes were treated with BCG and assayed for MKP-1 expression. Our results demonstrated that following exposure to BCG, there was an increase in the expression of MKP-1. Additionally, the induction of MKP-1 was regulated by p38 MAPK and extracellular signal-regulated kinase 1 and 2 (ERK1/2). Surprisingly, when MKP-1 expression was blocked by its specific siRNA, there was a significant decrease in the levels of phospho-MAPK (p38 MAPK and ERK1/2) and TNF-alpha inducible by BCG. CONCLUSIONS: Since TNF-alpha is pivotal in granuloma formation, the results indicated an unexpected positive function of MKP-1 against mycobacterial infection as opposed to its usual phosphatase activity.


Asunto(s)
Antibacterianos/farmacología , Fosfatasa 1 de Especificidad Dual/fisiología , Mycobacterium bovis/fisiología , Cisteína/análogos & derivados , Cisteína/farmacología , Inducción Enzimática , Humanos , Lipopolisacáridos/farmacología , Lipoproteínas/farmacología , Proteína Quinasa 1 Activada por Mitógenos/fisiología , Proteína Quinasa 3 Activada por Mitógenos/fisiología , Monocitos/fisiología , ARN Interferente Pequeño/farmacología , Transfección , Factor de Necrosis Tumoral alfa/biosíntesis , Factor de Necrosis Tumoral alfa/fisiología , Proteínas Quinasas p38 Activadas por Mitógenos/fisiología
3.
J Med Chem ; 52(21): 6707-15, 2009 Nov 12.
Artículo en Inglés | MEDLINE | ID: mdl-19835377

RESUMEN

Cimicifuga species have been used as traditional medicinal herbs to treat inflammation and symptoms associated with menopause in Asia, Europe, and North America. However, the underlying mechanism of their anti-inflammatory effects remains to be investigated. With bioactivity guided purification involving the use of partitioning extraction and high performance liquid chromatography, we isolated one of the key bioactive constituents from the rhizome extracts of Cimicifuga racemosa. By NMR spectroscopy, the molecule was identified to be cimiracemate A (1). This compound (140 muM) suppressed the lipopolysaccharide-induced TNF-alpha production in the blood macrophages by 47 +/- 19% and 58 +/- 30% at LPS concentrations of 1 ng/mL and 10 ng/mL, respectively. The anti-inflammatory activity of compound 1 may be due to its modulation of a signaling mitogen activated protein kinase and transcription factor nuclear factor-kappaB activities. Compound 1 was found in other Cimicifuga species. Our data indicate that compound 1 or its chemical analogues may have the potential to be further developed as a new class of therapeutic agent.


Asunto(s)
Antiinflamatorios no Esteroideos/aislamiento & purificación , Cimicifuga/química , Cinamatos/aislamiento & purificación , Macrófagos/efectos de los fármacos , Antiinflamatorios no Esteroideos/química , Antiinflamatorios no Esteroideos/farmacología , Células Cultivadas , Cromatografía Líquida de Alta Presión , Cinamatos/química , Cinamatos/farmacología , Regulación hacia Abajo , Humanos , Lipopolisacáridos/farmacología , Macrófagos/metabolismo , Espectroscopía de Resonancia Magnética , Proteínas Quinasas Activadas por Mitógenos/sangre , FN-kappa B/sangre , Extractos Vegetales/química , Rizoma/química , Factor de Necrosis Tumoral alfa/biosíntesis
4.
J Leukoc Biol ; 86(2): 283-91, 2009 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-19401395

RESUMEN

Mtb dysregulates monocyte/macrophage functions to produce a large amount of the immunosuppressive cytokine IL-10. An important function of IL-10 in promoting Mtb survival is the suppression of antigen presentation of monocytes/macrophages to T cells. This dampens the host immune responses and provides an opportunity for immune evasion. GSK3 has been shown to control the balance between pro- and anti-inflammatory cytokine productions. Here, we investigated whether GSK3 regulates IL-10 expression and mediates a protective role upon live mycobacterial challenge using BCG as a model. Our results showed that BCG increased Akt phosphorylation and inhibited GSK3 activity, resulting in increased IL-10 production. We confirmed further that suppression of GSK3 activities by a specific chemical inhibitor strongly enhanced BCG-induced IL-10 production. We also showed that IL-10 secreted by BCG-infected human PBMo was a major suppressor of subsequent IFN-gamma production by PBMC and HLA-DR expression on PBMo in response to BCG. Neutralization of PBMo-secreted IL-10 by anti-IL-10 antibodies restored the IFN-gamma production and HLA-DR surface expression. Taken together, GSK3 negatively regulates mycobacteria-induced IL-10 production in human PBMo. The kinase may play a role in restoring IFN-gamma secretions and subsequent antigen presentation in response to mycobacterial infection. In conclusion, our results suggest a significant role for GSK3 in guarding against mycobacterial evasion of immunity via IL-10 induction in the host.


Asunto(s)
Glucógeno Sintasa Quinasa 3/fisiología , Tolerancia Inmunológica/inmunología , Inmunidad Innata/inmunología , Interleucina-10/metabolismo , Infecciones por Mycobacterium/inmunología , Mycobacterium/inmunología , Anticuerpos/farmacología , Células Cultivadas , Regulación hacia Abajo/inmunología , Activación Enzimática/efectos de los fármacos , Activación Enzimática/inmunología , Inhibidores Enzimáticos/farmacología , Glucógeno Sintasa Quinasa 3/antagonistas & inhibidores , Glucógeno Sintasa Quinasa 3/metabolismo , Antígenos HLA-DR/metabolismo , Humanos , Interferón gamma/metabolismo , Interleucina-10/antagonistas & inhibidores , Monocitos/inmunología , Monocitos/microbiología , Infecciones por Mycobacterium/fisiopatología , Mycobacterium bovis/inmunología , Proteína Oncogénica v-akt/metabolismo , Fosforilación
5.
Int J Cancer ; 121(6): 1190-6, 2007 Sep 15.
Artículo en Inglés | MEDLINE | ID: mdl-17520672

RESUMEN

Induction of proinflammatory cytokines in response to malignant cells is an integral component of immune response to control tumor development. However, recent evidences have suggested that tumor cells may evade the immune system and exploit inflammatory responses to enhance its own growth. An exemplary example is the highly invasive and tumor necrosis factor (TNF)alpha-resistant glioblastoma, whose growth is associated with TNFalpha expression. We thus examined whether the tumor takes advantage of TNFalpha overexpression to enhance its invasiveness. To delineate the contribution of inflammation in tumor migration, we demonstrated that the role of proinflammatory cytokines on matrix metalloproteinases-3 (MMP-3) expression, and its consequent effects on the invasiveness of a human glioma cell-line, T98G. By using Matrigel Invasion Chamber, T98G cell migration was significantly enhanced in response to TNFalpha. In contrast, interferon-gamma (IFN gamma) reduced both basal and TNFalpha-enhanced cell invasion. To investigate the mechanisms involved, we demonstrated that TNFalpha upregulated mRNA and protein expression of MMP-3 in T98G cells, whereas IFN gamma downregulated the MMP-3 expression. The role of MMP-3 in glioma invasiveness was further confirmed by transfecting MMP-3 siRNA in T98G to abrogate the TNFalpha-enhanced cell invasion. To delineate the mechanisms further, we showed that IFN gamma exerts an inhibitory effect on the binding of TNFalpha-activated Ets-1 and NF kappa B to their respective enhancer elements found in MMP-3 promoter. In summary, our results indicated that TNFalpha enhances the invasiveness of T98G glioma cells through MMP-3 induction, and such enhancement of cell migration can be inhibited by IFN gamma.


Asunto(s)
Movimiento Celular/fisiología , Glioma/metabolismo , Interferón gamma/metabolismo , Metaloproteinasa 3 de la Matriz/biosíntesis , Factor de Necrosis Tumoral alfa/metabolismo , Línea Celular Tumoral , Ensayo de Cambio de Movilidad Electroforética , Expresión Génica , Glioma/inmunología , Humanos , Interferón gamma/inmunología , Metaloproteinasa 3 de la Matriz/inmunología , ARN Mensajero/análisis , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Factor de Necrosis Tumoral alfa/inmunología
6.
J Virol ; 81(1): 416-22, 2007 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-17035307

RESUMEN

Severe acute respiratory syndrome (SARS) is an emerging infectious disease caused by a novel coronavirus. Since its associated morbidity and mortality have been postulated to be due to immune dysregulation, we investigated which of the viral proteins is responsible for chemokine overexpression. To delineate the viral and cellular factor interactions, the role of four SARS coronavirus proteins, including nonstructural protein 1 (nsp-1), nsp-5, envelope, and membrane, were examined in terms of cytokine induction. Our results showed that the SARS coronavirus nsp-1 plays an important role in CCL5, CXCL10, and CCL3 expression in human lung epithelial cells via the activation of NF-kappaB.


Asunto(s)
Quimiocinas/genética , Coronavirus Relacionado al Síndrome Respiratorio Agudo Severo/patogenicidad , Proteínas no Estructurales Virales/metabolismo , Quimiocina CCL3 , Quimiocina CCL5 , Quimiocina CXCL10 , Quimiocinas/metabolismo , Quimiocinas CC/genética , Quimiocinas CC/metabolismo , Quimiocinas CXC/genética , Quimiocinas CXC/metabolismo , Regulación de la Expresión Génica , FN-kappa B/genética , FN-kappa B/metabolismo , Mucosa Respiratoria/citología , Mucosa Respiratoria/virología , Coronavirus Relacionado al Síndrome Respiratorio Agudo Severo/metabolismo , Proteínas del Envoltorio Viral/fisiología , Proteínas de la Matriz Viral/fisiología
7.
J Immunol ; 175(11): 7218-25, 2005 Dec 01.
Artículo en Inglés | MEDLINE | ID: mdl-16301626

RESUMEN

Following infection of the host by Mycobacterium tuberculosis, induction of cytokines is a major defense mechanism to limit the pathogen invasion. Cytokines interact with each other to form an intertwined network of pathways. For example, IFN and TNF have been shown to interact through common pathways including IFN-inducible, dsRNA-activated serine/threonine protein kinase (PKR) induction. As a signal transducer, it has been conventionally known to regulate the induction of cytokine expression in response to virus infection through NF-kappaB. In light of the critical role of TNF in immunity and its cytotoxic effects mediated by PKR, we examined the role of the kinase in the regulation of immune response against M. tuberculosis using the interaction of bacillus Calmette-Guérin (BCG) and primary human blood monocytes as a model. Our results showed that BCG stimulates the induction of cytokine expression in human primary blood monocytes including TNF-alpha, IL-6, and IL-10. With the suppression of PKR by using PKR-mutant gene or 2-aminopurine as PKR inhibitor, we showed that the BCG-induced cytokine expression in human monocytes is regulated by the phosphorylation and activation of PKR. We also demonstrated that downstream of PKR induction is the activation of MAPK and translocation of NF-kappaB into the nucleus. NF-kappaB in turn mediates the transcription of specific cytokine genes. Taken together, PKR plays a critical role in the regulation of immune responses to mycobacterial infection and may serve as an important molecule in the innate antimycobacterial defense.


Asunto(s)
Citocinas/biosíntesis , Monocitos/inmunología , Monocitos/microbiología , Infecciones por Mycobacterium/inmunología , eIF-2 Quinasa/metabolismo , Animales , Western Blotting , Ensayo de Cambio de Movilidad Electroforética , Expresión Génica , Humanos , Sistema de Señalización de MAP Quinasas/inmunología , Mycobacterium bovis/inmunología , FN-kappa B/inmunología , FN-kappa B/metabolismo , Fosforilación , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Células U937 , eIF-2 Quinasa/inmunología
8.
FEBS Lett ; 579(14): 3055-62, 2005 Jun 06.
Artículo en Inglés | MEDLINE | ID: mdl-15907845

RESUMEN

HIV Tat has been known to have multiple regulatory roles including replication of HIV and modulation of cellular kinases. We investigated whether signaling kinase PKR plays a critical role in mediating Tat-induced cytokine dysregulation. We showed Tat induction of IL-10 dysregulation is associated with PKR activation. To examine the mechanism involved, inhibition of PKR activity abrogated the Tat-induced cytokine induction. We next identified that the MAP kinases including ERK-1/2 and p38 are downstream of PKR in these Tat-induced pathways. Thus, PKR may play a critical role in mediating the subversive effects of HIV Tat resulting in IL-10 induction.


Asunto(s)
Citocinas/genética , Citocinas/metabolismo , Quinasas MAP Reguladas por Señal Extracelular/metabolismo , Productos del Gen tat/metabolismo , Sistema de Señalización de MAP Quinasas , eIF-2 Quinasa/inmunología , eIF-2 Quinasa/metabolismo , Proteína delta de Unión al Potenciador CCAAT , Proteínas Potenciadoras de Unión a CCAAT/metabolismo , Células Cultivadas , Citocinas/biosíntesis , Citocinas/inmunología , Relación Dosis-Respuesta a Droga , VIH-1 , Humanos , Interleucina-10/biosíntesis , Interleucina-10/genética , Interleucina-10/metabolismo , Leucocitos/metabolismo , FN-kappa B/metabolismo , Factores de Tiempo , Factores de Transcripción/metabolismo , Regulación hacia Arriba , eIF-2 Quinasa/antagonistas & inhibidores , Proteínas Quinasas p38 Activadas por Mitógenos/metabolismo , Productos del Gen tat del Virus de la Inmunodeficiencia Humana
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA